Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reguera

Showing results (871-880 of 896) with videos related to

Pageof 90
Sort By:
Blood Advances|November 27, 2024
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myelomaInés Zugasti, Marta Tormo-Ratera, Aina Oliver-Caldés, et al.
Archivos De Bronconeumologia|January 31, 2025
Development and Comparison of Reference Equations for the Six-Minute Walk Test in Spanish Healthy Adults Aged 45-85 YearsElena Gimeno-Santos, Jordi Vilaró, Ane Arbilllaga-Etxarri, et al.
The Lancet. Oncology|July 6, 2023
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot studyAina Oliver-Caldés, Verónica González-Calle, Valentín Cabañas, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 2, 2021
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM RegistryFelipe Alvarez-Manceñido, Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, et al.
Communications Medicine|January 12, 2026
A matched case-control study on Escherichia coli factors contributing to sepsis and septic shock in bacteraemic patientsNatalia Maldonado, Inmaculada López-Hernández, John Karlsson Valik, et al.
The Lancet. Microbe|March 28, 2024
Whole-genome characterisation of Escherichia coli isolates from patients with bacteraemia presenting with sepsis or septic shock in Spain: a multicentre cross-sectional studyNatalia Maldonado, Inmaculada López-Hernández, Andrea García-Montaner, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 11, 2025
Validation and normative data for the BAC app in Spanish-speaking individuals with psychosis and healthy controlsCésar González-Blanch, Esther Pousa, Pablo Reguera-Pozuelo, et al.
Blood Neoplasia|April 24, 2026
Single-cell multiomics reveals regulatory mechanisms of CAR T-cell persistence and dysfunction in multiple myelomaLorea Jordana-Urriza, Guillermo Serrano, Sergio Camara-Peña, et al.
British Journal of Haematology|June 19, 2024
Serum mass spectrometry for treatment monitoring in patients with multiple myeloma receiving ARI0002h CAR T-cellsIñaki Ortiz de Landazuri, Aina Oliver-Caldés, Marta Español-Rego, et al.
Therapeutic Advances in Medical Oncology|March 10, 2023
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapyPaula Jimenez-Fonseca, Victoria Foy, Sophie Raby, et al.
Pageof 90

Showing results (871-880 of 896) with videos related to

Sort By:
Pageof 90
Blood Advances|November 27, 2024
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myelomaInés Zugasti, Marta Tormo-Ratera, Aina Oliver-Caldés, et al.
Archivos De Bronconeumologia|January 31, 2025
Development and Comparison of Reference Equations for the Six-Minute Walk Test in Spanish Healthy Adults Aged 45-85 YearsElena Gimeno-Santos, Jordi Vilaró, Ane Arbilllaga-Etxarri, et al.
The Lancet. Oncology|July 6, 2023
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot studyAina Oliver-Caldés, Verónica González-Calle, Valentín Cabañas, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 2, 2021
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM RegistryFelipe Alvarez-Manceñido, Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, et al.
Communications Medicine|January 12, 2026
A matched case-control study on Escherichia coli factors contributing to sepsis and septic shock in bacteraemic patientsNatalia Maldonado, Inmaculada López-Hernández, John Karlsson Valik, et al.
The Lancet. Microbe|March 28, 2024
Whole-genome characterisation of Escherichia coli isolates from patients with bacteraemia presenting with sepsis or septic shock in Spain: a multicentre cross-sectional studyNatalia Maldonado, Inmaculada López-Hernández, Andrea García-Montaner, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 11, 2025
Validation and normative data for the BAC app in Spanish-speaking individuals with psychosis and healthy controlsCésar González-Blanch, Esther Pousa, Pablo Reguera-Pozuelo, et al.
Blood Neoplasia|April 24, 2026
Single-cell multiomics reveals regulatory mechanisms of CAR T-cell persistence and dysfunction in multiple myelomaLorea Jordana-Urriza, Guillermo Serrano, Sergio Camara-Peña, et al.
British Journal of Haematology|June 19, 2024
Serum mass spectrometry for treatment monitoring in patients with multiple myeloma receiving ARI0002h CAR T-cellsIñaki Ortiz de Landazuri, Aina Oliver-Caldés, Marta Español-Rego, et al.
Therapeutic Advances in Medical Oncology|March 10, 2023
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapyPaula Jimenez-Fonseca, Victoria Foy, Sophie Raby, et al.
Pageof 90